Monte, AP; Marona-Lewicka, D; Cozzi, NV; Nichols, DE. Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine J. Med. Chem., 1 Nov 1993, 36 (23), 3700–3706. 1.0 MB. https://doi.org/10.1021/jm00075a027 #5 MS,NMR
Cozzi, NV. Pharmacological studies of some psychoactive phenylalkylamines: entactogens, hallucinogens, and anorectics Ph. D. Thesis, University Of Wisconsin-Madison, 1 Jan 1994. 10.6 MB. #5-BA LC,MS,NMR
Casale, JF; Hays, PA. The characterization of 5- and 6-(2-aminopropyl)-2,3-dihydrobenzofuran Microgram J., 1 Jan 2011, 8 (2), 62–74. 1.0 MB. #1 GC,MS,NMR,IR
Casale, JF. Letter to the editor regarding: Abbreviations for 5- and 6-(2-aminopropyl)-2,3-dihydrobenzofuran vs. 5- and 6-(2-aminopropyl)benzofuran: A clarification of “APB” and “APDB” Microgram J., 1 Jan 2012, 9 (1), 46. 220 kB. #5-APDB
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #15
King, LA. New phenethylamines in Europe Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
Nichols, DE. Medicinal chemistry and structure-activity relationships In Amphetamine and its Analogs; Cho, AK; Segal, DS, Eds., Academic Press, San Diego, CA, 1 Jan 1994; pp 3–41. 8.1 MB. #26
Simmler, LD; Liechti, ME. Pharmacology of MDMA- and amphetamine-like new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 143-164. 298 kB. https://doi.org/10.1007/164_2018_113
Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Benzofurans 5-APDB
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. Analytical data of designer drugs of synthetic phenethylamines JCCL, 1 Dec 2015, (55), 43–63. 637 kB. #11 Japanese, English abstract MS,NMR,IR,UV
Nishimura, Y; Tanaka, S; Ikeda, H; Yamazaki, Y. Study of method for identifying regioisomers of controlled drugs JCCL, 1 Dec 2015, (55), 65–85. 707 kB. #5-APDB Japanese, English abstract GC,MS,UV
Uchiyama, N; Matsuda, S; Kawamura, M; Shimokawa, Y; Kikura-Hanajiri, R; Aritake, K; Urade, Y; Goda, Y. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products Forensic Sci. Int., 1 Oct 2014, 243, 1–13. 742 kB. https://doi.org/10.1016/j.forsciint.2014.03.013 #15, 5-APDB GC,LC,MS,NMR,UV
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #D1 LC